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 1 
Abstract 23 
Gambling disorder affects 0.4 to 1.6% of adults worldwide, and is highly comorbid with other 24 
mental health disorders. This article provides a concise primer on the neural and psychological 25 
underpinnings of gambling disorder based on a selective review of the literature. Gambling 26 
disorder is associated with dysfunction across multiple cognitive domains which can be 27 
considered in terms of impulsivity and compulsivity. Neuroimaging data suggest structural and 28 
functional abnormalities of networks involved in reward processing and top-down control. 29 
Gambling disorder shows 50-60% heritability and it is likely that various neurochemical systems 30 
are implicated in the pathophysiology (including dopaminergic, glutamatergic, serotonergic, 31 
noradrenergic, and opioidergic). Elevated rates of certain personality traits (e.g. negative 32 
urgency, disinhibition), and personality disorders, are found. More research is required to 33 
evaluate whether cognitive dysfunction and personality aspects influence the longitudinal course 34 
and treatment outcome for gambling disorder. It is hoped that improved understanding of the 35 
biological and psychological components of gambling disorder, and their interactions, may lead 36 
to improved treatment approaches and raise the profile of this neglected condition.  37 
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1. Introduction 41 
Gambling disorder is characterized by persistent and recurrent maladaptive patterns of gambling 42 
behavior, leading to impaired functioning (1). Although most people who engage in gambling do 43 
so responsibly and without consequent functional impairment, some individuals find that they 44 
become preoccupied with gambling and cannot control their behavior despite multiple negative 45 
consequences (2). Surveys suggest that the prevalence of gambling disorder in the general United 46 
States population ranges from 0.42% to 1.9%, and similar rates have been reported  worldwide 47 
(3-5). As such, recognition of why some individuals cannot control their gambling behavior 48 
appears worthy of attention from a global public health perspective (6). In recognition of 49 
Gambling disorder representing a prototypical ‘behavioral addiction’, it has been recently 50 
reclassified as a ‘Substance-Related and Addictive Disorder) in the Diagnostic and Statistical 51 
Manual Version 5 (DSM-5) (1). 52 
 53 
There exist several comprehensive reviews of specific aspects of gambling disorder (7-12). The 54 
aim of this paper is to provide a concise primer examining the neurobiological and psychological 55 
underpinnings of gambling disorder, incorporating recent evidence derived from the 56 
neurosciences. We highlight implications for new treatment directions, along with limitations of 57 
this approach and areas in which research is lacking.  58 
 59 
2. Pathophysiology of gambling disorder 60 
The behaviors that characterize gambling disorder can be regarded as impulsive, in that they are 61 
often poorly thought out (or undertaken without adequate forethought), risky, and result in 62 
deleterious long-term outcomes (13). Developmentally, impulsive behavior that underlies 63 
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gambling disorder tends to begin during late adolescence or early adulthood (14). While the 64 
longitudinal profile of Gambling disorder has received little research attention, for some 65 
individuals it is likely that patterns of behavior become ingrained and persist over time, 66 
especially in the absence of prompt treatment interventions (3, 9).  67 
 68 
2.1. Neurocognition 69 
People with gambling disorder often manifest cognitive deficits consistent with tendencies 70 
towards impulsivity. Objective brain-based measurable traits that deconstruct top-level 71 
phenotypes into meaningful markers more closely related to the underlying etiology are 72 
important in trying to understand the neurobiology of Gambling disorder and its relationship 73 
with other conditions (15). Deficits in aspects of inhibition, working memory, planning, 74 
cognitive flexibility, and time management/estimation have been reported in individuals with 75 
gambling disorder compared to healthy volunteers (12). Individuals with gambling disorder also 76 
tend to prefer small immediate rewards rather than larger delayed rewards, to the detriment of 77 
long-term task outcomes (i.e. they show abnormally elevated ‘delay discounting’) (16).  78 
 79 
Impulsivity is not the only aspect of gambling disorder with other cognitive domains likely 80 
present to varying degrees in gambling disorder. Gambling disorder for many individuals, for 81 
example, is associated with features of compulsivity (17). People with gambling disorder often 82 
describe the behavior in ritualistic terms such as the need for “lucky” numbers or clothing to 83 
result in favorable outcome. In addition, the nature of gambling behavior may change over time, 84 
with early gambling being driven by reward, and later (more chronic) gambling being triggered 85 
by aversive/stressful stimuli (3), or being undertaken in order to avert anxiety (17). As such, 86 
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there may be a shift from an initial behavior that is reward-seeking (impulsive) towards one that 87 
persists to avoid negative consequences or in a habitual fashion (compulsive). Individuals with 88 
gambling disorder often score high on the Padua Inventory, a measure of compulsivity (18) and 89 
display marked response perseveration (19,20) and difficulties with cognitive flexibility (21).  90 
 91 
Although studies of gambling disorder demonstrate that the behavior is associated with 92 
diminished performance on inhibition, time estimation, cognitive flexibility, decision-making, 93 
spatial working memory, and planning tasks, a temporal relationship has not been established 94 
between cognitive deficits and clinically significant symptoms. Most likely, some cognitive 95 
deficits predispose (perhaps running in families and representing candidate ‘endophenotypes’ or 96 
intermediate markers of risk), while others could be a consequence of recurrent engagement in 97 
gambling itself. While studies of cognitive functioning in unaffected close relatives of people 98 
with gambling disorder are lacking, findings from people ‘at-risk’ of gambling disorders suggest 99 
that deficits in decision-making (dependent on neural circuitry including the orbitofrontal and 100 
insular cortices) are evident before the illness, while some other domains may be relatively 101 
spared (22). Gambling addiction represents a useful model for exploring the ‘cause versus effect’ 102 
issue in addiction more broadly, since chronic gambling is presumably unlikely to exert toxic 103 
effects on the brain, as compared to chronic substance misuse.  104 
 105 
2.2. Neuroimaging 106 
A sparse amount of research on possible neurobiological correlates of gambling disorder 107 
currently exists (for reviews, please see 11-12). Most studies have focused on functional rather 108 
than structural neuroimaging abnormalities. One functional magnetic resonance imaging (fMRI) 109 
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study of gambling urges in male pathological gamblers suggested that gambling disorder is 110 
associated with relatively decreased activation within cortical, basal ganglionic and thalamic 111 
brain regions compared to control subjects (23). Recent neuroimaging studies have demonstrated 112 
that gamblers also show hyporesponsiveness of the dorsomedial prefrontal cortex compared to 113 
healthy controls during successful (as well as failed) response inhibition, along with  a 114 
hypoactive reward system (24-26). Using a graph theoretical approach (network modeling), there 115 
was evidence for abnormalities in distributed brain networks in gambling disorder versus 116 
controls, such as reduced local efficiency in the left supplementary motor area, and 117 
hyperconnectivity between frontal brain regions including the right inferior frontal gyrus (27).    118 
In terms of brain structure, there is some evidence that gambling disorder is associated with 119 
excess volume of the ventral striatum and right prefrontal cortex (28).  120 
 121 
Another area of neuroimaging research in gambling disorder is the use of radioligand measures 122 
in conjunction with positron emission tomography (PET). Using this technique, the status of 123 
neurochemical systems in people with gambling disorder, both in the resting state and in 124 
response to pharmacological challenge, can be explored. Research so far has focused on the 125 
dopamine system, given its established importance in substance addiction and more generally in 126 
reward-processing (29). In substance addictions, there is considerable evidence that chronic 127 
substance intake is associated with downregulation of striatal D2 receptors (30). Interestingly, 128 
radioligand studies so far suggest that gambling disorder is not associated with such 129 
dopaminergic D2 downregulation. In a study using raclopride (D2/D3 receptor binding) and 130 
propyl-hexahydro-naphtho-oxazin (PHNO; D3 receptor binding), no significant differences in 131 
inferred striatal dopamine receptor binding were found between people with gambling disorder 132 
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and healthy controls (31). However, PHNO binding in the substantia nigra correlated 133 
significantly with gambling symptom severity. In another study, using raclopride (D2/D3 134 
receptor binding), no significant differences were found between gambling disorder subjects and 135 
controls in terms of inferred striatal dopamine receptor binding (32); but ‘urgency’ correlated 136 
negatively with raclopride binding in the gambling disorder group. Another study, using 137 
raclopride, similarly reported no group differences between gambling disorder and controls; but 138 
did find that dopamine receptor binding was associated with sensation-seeking in general (33). In 139 
all, these radioligand studies suggest that D2 receptor downregulation is not a general feature of 140 
gambling disorder, in contrast to findings in substance use disorders. This is consistent with the 141 
view that D2/D3 receptor abnormalities in substance use disorders are a consequence of the 142 
effects of chronic drug intake on the reward pathways. Dopamine status is relevant to 143 
personality-related factors (e.g. sensation-seeking) implicated in the development of gambling 144 
disorder. It may also be that other aspects of the dopamine system, not measured using the above 145 
ligands, are abnormal in gambling disorder. For example, one raclopride-PET study found an 146 
inverted ‘U’ relationship between striatal dopamine release and gambling task performance in 147 
pathological gamblers but not in controls, suggesting enhanced dopaminergic sensitivity to 148 
uncertainty in gamblers (34).  149 
 150 
Neuroimaging studies to date, do not permit characterization of the temporal relationship 151 
between the manifestation of neural abnormalities and the symptoms that comprise gambling 152 
disorder. As with the neurocognitive findings, abnormal brain structure and function could occur 153 
in people ‘at-risk’ before symptoms develop, alternatively stem from the disorder itself, or 154 
perhaps even reflect a secondary or incidental epiphenomenon. 155 
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2.3. Genetic predisposition 157 
Studies have found that approximately 20% of the first-degree relatives of individuals with 158 
gambling disorder also have gambling disorder (3). Research examining familial aggregation of 159 
gambling disorder found that individuals with a problem gambling parent were 3.3 times more 160 
likely to have gambling disorder (35). In a study using a control group to examine familial 161 
aggregation, lifetime estimates of gambling disorder were significantly higher in family members 162 
of gamblers (8.3%) compared to control subjects (2.1%) (36). Data from the Vietnam Era Twin 163 
Registry (male adults) have shown that the heritability of gambling disorder is approximately 50-164 
60% (37-38). Further analyses of personality features and their association with the heritability 165 
of gambling disorder have found that low self-control is associated with the genetic risk for 166 
gambling disorder in women (39). As discussed in the subsequent section, various 167 
polymorphisms in genes coding for components of brain neurochemical systems (e.g. 168 
dopaminergic and serotonergic systems) have been associated with gambling disorder.  169 
 170 
2.4. Neurobiological factors 171 
Multiple neurotransmitter systems (e.g., dopaminergic, glutamatergic, serotonergic, 172 
noradrenergic, opioidergic) have been implicated in the pathophysiology of gambling disorder 173 
(3, 40-41). Dopamine is involved in learning, motivation, and the salience of stimuli, including 174 
rewards.  As discussed in section 2.3, radioligand PET studies militate against an obvious D2/D3 175 
receptor binding abnormality being evident in gambling disorder in the resting state. 176 
Nonetheless, alterations in dopaminergic pathways have been proposed as underlying the seeking 177 
of rewards that trigger the release of dopamine and produce feelings of pleasure. In addition, 178 
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neuroimaging studies examining pharmacological challenges using dopamine agonists have 179 
reported that during the anticipation of monetary rewards, a dopamine agonist increases the 180 
activity of the nucleus accumbens and weakens the interaction between the nucleus accumbens 181 
and the prefrontal cortex, leading to an increase in impulsive behaviors (42). Dopamine receptor 182 
agonist medication appears to predispose the dopaminergic reward system to mediate an 183 
increased appetitive drive leading to changed neural processing of negative consequences and 184 
learning of contingencies (43). In terms of molecular genetic studies, the D2A1 allele of the D2 185 
dopamine receptor gene (DRD2) has been reported as increased in frequency in individuals with 186 
gambling disorder (for a review see 39). Other research has also implicated allelic variants of the 187 
DRD1 and DRD3 genes as having an association with gambling disorder (3).  188 
 189 
There is also a persuasive body of preclinical evidence suggesting a critical role for glutamate 190 
transmission and glutamate receptors in drug reward, reinforcement, and relapse. Glutamate 191 
appears to be implicated in long-lasting neuroadaptations in the corticostriatal circuitry (44).  An 192 
imbalance in glutamate homeostasis results in changes in neuroplasticity that adversely affects 193 
communication between the prefrontal cortex and the nucleus accumbens, thereby resulting in 194 
reward-seeking behaviors (45). Glutamate is also involved in associative learning between 195 
stimuli and promotes the immediate approach response through its link to the 196 
dopamine reward system (41).  Data from cerebrospinal fluid studies also suggest a 197 
dysfunctional glutamate system in gambling disorder (46). 198 
 199 
Animal studies of gambling behavior provide evidence that the serotonergic system also appears 200 
to play a role in poor decision-making (47) and impaired performance on a gambling task (48).  201 
 9 
Serotonin is known as a modulator of neuroplasticity events. A polymorphism in the serotonin 202 
transporter gene has been associated with gambling disorder and is found more frequently in 203 
males with gambling disorder (49). More recent research found a significant association of the 204 
C/C genotype of the serotonin receptor 2A T102C (rs 6313) polymorphism and the gambling 205 
disorder phenotype (50). Other support for dysfunction within the serotonergic system in 206 
gambling disorder has been shown with decreased levels of platelet monoamine oxidase B 207 
(MAO-B) (a peripheral marker of serotonergic function), low levels of serotonin metabolites (5-208 
HIAA) in the cerebrospinal fluid, and a euphoric response to serotonergic pharmacologic 209 
challenge studies (3, 40). 210 
 211 
 Norepinephrine (noradrenaline) appears to be especially involved in decision-making when 212 
contingencies are unexpectedly changed and alternatives are explored (51-52). Selective 213 
inhibition of norepinephrine reuptake results in reduced premature responding, especially under 214 
circumstances when task performance is suboptimal due to demanding task conditions or 215 
inherently high baseline levels of impulsive action (53-54). Studies have found that individuals 216 
with gambling disorder have significantly higher cerebrospinal fluid levels of 3-methoxy-4-217 
hydroxy-phenylglycol, the main metabolite of the noradrenergic system (55).  In addition, 218 
individuals with gambling disorder maintained significantly higher noradrenergic levels 219 
throughout an entire gambling session whereas healthy controls exhibited elevated levels only at 220 
the onset of the gambling session (56). 221 
 222 
Preclinical evidence indicates that opioid receptors are distributed widely in the mesolimbic 223 
system, and are implicated in the hedonic aspects of reward processing (57-58).   224 
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 225 
An fMRI study of the μ-opioid antagonist naloxone found attenuated reward-related responses in 226 
the ventral striatum and enhanced loss-related activity in the medial prefrontal cortex on a wheel 227 
of fortune task in healthy volunteers (59). Specifically, the authors used an fMRI gambling task 228 
and found that naloxone reduced pleasure ratings for larger rewards and dampened the associated 229 
brain responses in the anterior cingulate cortex. Naloxone was also associated with negative 230 
outcomes being rated  as being more unpleasant, implicating the opioid system both in reward- 231 
and aversive-processing (59). Gambling has been associated with elevated blood levels of the 232 
endogenous opioid β-endorphin (60), and modulation of the opioid system through opioid 233 
receptor antagonists (61) and partial agonists (62-63) has shown significant promise in the 234 
treatment of gambling disorder.   235 
 236 
3. Psychological aspects of gambling disorder 237 
Relationships between gambling disorder and aspects of personality can be considered from 238 
several perspectives, including in relation to personality traits (typically measured using 239 
questionnaires such as the Barratt Impulsivity Questionnaire), in relation to formal personality 240 
disorders, and in relation to other potentially life-long enduring traits (such as aspects of 241 
cognition).  242 
 243 
3.1. Gambling disorder and personality traits 244 
The assessment of personality traits is an evolving field. While questionnaire-based measures 245 
relating to personality have proven useful in exploring aspects of gambling disorder, it can be 246 
difficult to relate them to underlying brain function (64-65).  247 
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 248 
Support for impulsivity as a personality characteristic of individuals with gambling disorder 249 
rather than transient impulsive behavior, comes from numerous studies over the years (for a 250 
review, please see 66), including a recent study of 37 individuals which found that trait, rather 251 
than state, questionnaire-based impulsivity is associated with gambling disorder (67).  252 
 253 
The relationship between impulsivity and gambling, however, may be impacted by a variety of 254 
factors, including socioeconomic status, age of onset, and gender.  One study found that self-255 
reported impulsivity was associated with the onset of gambling behavior but only in the case of 256 
individuals reporting a low socioeconomic background (68). Similarly, in a sample of 1004 257 
males from low socioeconomic status areas, impulsivity at age 14 was related to gambling 258 
problems at age 17 (69).  With respect to age of onset, one study found that early onset gambling 259 
disorder was associated with a more severe clinical presentation and with higher novelty seeking 260 
and lower self-directedness (70). In addition, gender appears to have an influence on impulsivity, 261 
as men with gambling problems may be more impulsive and score higher on measures of 262 
sensation-seeking compared to women (71).   263 
 264 
Several researchers have attempted to categorize gambling disorder based on dimensions of 265 
personality, such as impulsivity, and co-occurring psychopathology.  One study identified three 266 
subtypes of gambling disorder based on self-report questionnaires measuring impulsivity, 267 
depression, and anxiety (72). The first subtype consists of behaviorally conditioned gamblers, 268 
who develop gambling disorder through continual exposure to gambling and is the least severe 269 
type of gambling disorder. A second type, the emotionally vulnerable individual, has poor coping 270 
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skills, and gambles to regulate emotions. Third, antisocial impulsivity gamblers gamble to 271 
regulate affect, but are also characterized by high rates of psychopathology and impulsivity. 272 
 273 
Another study sought to categorize gamblers into four groups (73): Cluster 1 had high 274 
impulsivity, rates of psychopathology, early onset, and severe gambling problems; Cluster 2 had 275 
low sensation seeking and high avoidant, controlling, and distant behavior, with high rates of 276 
alcohol abuse; Cluster 3 was characterized by high impulsivity and early onset, but also had high 277 
rates of sensation seeking without psychopathological impairments; and Cluster 4 was defined by 278 
low impulsivity and psychopathology, and a late age of onset.  279 
 280 
In a meta-analysis of studies, significantly higher rates of several personality traits were 281 
identified in people with gambling disorder compared to controls (medium-large effect sizes), 282 
including negative urgency, low premeditation, unconscientious disinhibition (low 283 
conscientiousness), negative affect, and disagreeable disinhibition (low agreeableness) (74). The 284 
authors suggested that these findings in gambling disorder were similar to those observed in 285 
substance use disorders, suggesting that it may be part of a broader group of conditions 286 
characterized by externalizing psychopathology.  287 
 288 
Some personality traits have been found to correlate with dopamine functioning. For example, in 289 
healthy males, it was found that striatal dopamine receptor binding (measured using raclopride-290 
PET) correlated with sensation-seeking according to an inverted ‘U’ shaped model (75). As 291 
noted in section 2.2, dopamine receptor binding – again with raclopride-PET – was associated 292 
with sensation-seeking across gambling disorder and control subjects (33).  293 
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Current research has just begun to examine how personality dimensions and disorders influence 294 
treatment outcome. One study found that treatment dropout was significantly related to 295 
impulsivity (76). Other studies have found that although certain personality aspects such as high 296 
novelty seeking have been associated with more severe gambling and a young age of gambling 297 
disorder onset, these variables were not associated with treatment outcome (70).   298 
 299 
3.2. Gambling disorder and personality disorders 300 
 301 
Personality disorders appear to be relatively common in people with gambling disorder, and are 302 
likely to contribute to chronic symptoms. In one study, 45.5% of individuals with gambling 303 
disorder met criteria for at least one personality disorder  (76). However, the presence of a 304 
personality disorder was not clearly related with the severity of gambling symptoms.  305 
 306 
There is evidence that rates of personality disorders in gambling disorder may be influenced by 307 
other psychiatric comorbidities. In a sample derived from a national survey, one or more 308 
personality disorders was evident in 71.4% of gambling disordered individuals with a comorbid 309 
anxiety disorder (versus 40.86% of low frequency gamblers with an anxiety disorder), and in 310 
52.9% of gambling disordered individuals without a comorbid anxiety disorder (versus 11.3% of 311 
low frequency gamblers without an anxiety disorder) (77).   312 
 313 
 314 
3.3. Gambling disorder and other potentially enduring traits 315 
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It is conceivable that some of the cognitive deficits that occur in Gambling disorder could 316 
represent enduring traits that predispose towards the development of symptoms. As such, 317 
cognitive measures may be useful as proxy ‘personality measures’ in that they may be enduring 318 
and more readily linked to underlying neurobiology than formal personality disorders or scores 319 
from personality questionnaires. In order to examine impulsivity at an endophenotypic level, 320 
cognitive research has attempted to delineate the complex construct of impulsivity observed in 321 
individuals with gambling disorder. Individuals with gambling disorder demonstrate deficiencies 322 
in planning, decision-making, motor inhibition, and cognitive flexibility (3).  Perceived inability 323 
to stop gambling and positive gambling expectancies have also been associated with high school 324 
students, college students, and adults with gambling disorder (78).  However, it is not known the 325 
extent to which these different deficits are trait in nature. To address this issue would require 326 
studies in unaffected first degree relatives and also, ideally, longitudinal studies capturing 327 
cognitive function before, during, and after the development of Gambling disorder. There is 328 
some evidence that decision-making deficits could represent a trait marker, based on findings in 329 
people at risk of gambling disorder but without fully developed pathological symptoms (22).  330 
 331 
 332 
4. Conclusions 333 
The literature suggests that gambling disorder is a heterogeneous condition; however, 334 
impulsivity appears to be characteristic of the majority of individuals with gambling disorder.  335 
The relatively paucity of neuroimaging data (especially functional imaging), genetic studies, and 336 
translational studies from animals to humans in gambling disorder, however, limits our ability in 337 
defining gambling disorder as a deficit of a particular component(s) of the brain although 338 
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dysfunction in dopaminergic, glutamatergic, and serotonergic transmission have all been 339 
implicated.  Further, the evidence of a genetic link between gambling disorder and other 340 
addictive behaviors is supported by high rates of familial transmission and the cross-beneficial 341 
efficacy of opioid antagonists and partial agonists in gambling and substance addiction. More 342 
holistic studies involving a number of research paradigms (genetics, cognition, imaging, etc) that 343 
explore the pathology of gambling disorder over time may be useful in furthering our 344 
understanding of the onset and course of gambling disorder. 345 
346 
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